Brian E. Schwartz

机构：VistaGen Therapeutics (United States) · ORCID：0000-0002-4659-9800

发表论文 28 篇 · 总被引 6268 次 · h-index 13

代表论文

• Selective inhibition of BET bromodomains (2010 · Nature · 被引 4336)
• Diagnosis of NUT Midline Carcinoma Using a NUT-specific Monoclonal Antibody (2009 · The American Journal of Surgical Pathology · 被引 437)
• Transcriptional activation triggers deposition and removal of the histone variant H3.3 (2005 · Genes & Development · 被引 319)
• Differentiation of NUT Midline Carcinoma by Epigenomic Reprogramming (2011 · Cancer Research · 被引 222)
• Oncogenesis by sequestration of CBP/p300 in transcriptionally inactive hyperacetylated chromatin domains (2010 · The EMBO Journal · 被引 191)
• Transcriptional and Developmental Functions of the H3.3 Histone Variant in Drosophila (2009 · Current Biology · 被引 183)